Plante Moran Financial Advisors’s Pacira BioSciences PCRX Stock Holding History

Plante Moran Financial Advisors’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-428	Closed	-$14K	–	828
2018 Q2	$14K	Hold	428	–	–	0.01%	514
2018 Q1	$13K	Hold	428	–	–	0.01%	568
2017 Q4	$20K	Hold	428	–	–	0.01%	500
2017 Q3	$16K	Hold	428	–	–	0.01%	488
2017 Q2	$20K	Hold	428	–	–	0.01%	473
2017 Q1	$20K	Hold	428	–	–	0.01%	484
2016 Q4	$14K	Hold	428	–	–	0.01%	535
2016 Q3	$15K	Hold	428	–	–	0.01%	533
2016 Q2	$14K	Hold	428	–	–	0.01%	481
2016 Q1	$23K	Sell	428 -13	-3%	-$760	0.02%	364
2015 Q4	$34K	Buy	441 +291	+194%	+$16.5K	0.03%	361
2015 Q3	$6K	Hold	150	–	–	﹤0.01%	561
2015 Q2	$11K	Hold	150	–	–	0.01%	511
2015 Q1	$13K	Hold	150	–	–	0.01%	477
2014 Q4	$13K	Hold	150	–	–	0.01%	486
2014 Q3	$15K	Hold	150	–	–	0.01%	455
2014 Q2	$14K	Hold	150	–	–	0.01%	442
2014 Q1	$10K	Hold	150	–	–	0.01%	370
2013 Q4	$9K	Sell	150 -100	-40%	-$5.26K	0.01%	472
2013 Q3	$12K	Hold	250	–	–	0.01%	369
2013 Q2	$7K	Buy	+250	New	+$7.23K	0.01%	408

Other funds holding PCRX

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Plante Moran Financial Advisors's PCRX Position: Q3 2018 in Review

Plante Moran Financial Advisors sold out of Pacira BioSciences (PCRX) in Q3 2018, closing a stake of 428 shares — an estimated $14K sold.

Plante Moran Financial Advisors first reported a position in PCRX in Q2 2013 and held it in 21 quarters. The position peaked at $34K in Q4 2015. 187 funds tracked by Wall St. Rank hold PCRX as of Q3 2018.

Plante Moran Financial Advisors reported no remaining Pacira BioSciences position as of Q3 2018 after selling out during the quarter.
Plante Moran Financial Advisors sold 428 Pacira BioSciences shares in Q3 2018, an estimated $14K.
Plante Moran Financial Advisors first reported a position in Pacira BioSciences in Q2 2013 and held it in 21 quarters.
Plante Moran Financial Advisors's Pacira BioSciences position peaked at $34K in Q4 2015.
187 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2018.

Based on Plante Moran Financial Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.